
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
The Cape Cod Symposium on Addictive Disorders is a large annual meeting dedicated to continuing education and networking in the field of addictions.
The Cape Cod Symposium on Addictive Disorders is a large annual meeting dedicated to continuing education and networking in the field of addictions. In 2009, 793 attendees from 47 states and 10 countries attended. The Symposium combines workshops and seminars on relevant industry topics with a varied showcase of the industry's products and services. This year's Symposium takes place on September 8-11, 2011.




